Cancer therapy and treatment have become one of the most researched and highly funded therapeutic areas, with many organisations tackling treatment in this area of disease, given its high incidence within the population globally.
Spectrum of oncology
Cancer medicines and drug treatments are used to target mutations or shore up the immune system of patients, and have greatly increased the effectiveness of treatment for patients suffering from various forms of cancer, lengthening the life expectancy for many.
At Charnwood Molecular, we work across the entire spectrum of oncology and immuno-oncology drug discovery, with activities in target identification and lead optimisation through to candidate nomination and clinical positioning. Our teams work together across a range of disciplines to provide tailored solutions to our clients in the areas of oncology and immuno-oncology.
At the leading edge
With the massive push for research in these areas, the field of oncology is continuously changing. In conjunction with our clients working in the field, we are at the leading edge of this type of research.
Offering a fully integrated solution, Charnwood Molecular can add value to any client project in this therapeutic area.
Oncology assays and therapeutics
Assays available to support oncology projects include:
- Exhaustion assays
- Suppression assays
- Kinase screens
- Cell Division
- Cell signaling
- Small molecule
Our track record
Take a look at examples of work we have carried out in this area:
- Delivery of highly potent compounds with good ADME properties, clear SAR and vivo efficacy
- Screening campaign that identified novel potent hit series with clear SAR
- How we supported Carrick Therapeutics in the development of the anti-cancer therapeutic CT7001
- Targeting hypoxia for cancer
You can also download our eBook on developing effective assays: